STADA Arzneimittel AG
27.08.2012 16:58
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Pursuant to section 21 (1) WpHG ('German Securities Trading Act'), SKAGEN
AS, Skagen 3, 4006 Stavanger, Norway, notified us on 27th of August 2012
that fund SKAGEN Kon-Tiki verdipapirfond managed by SKAGEN AS reduced its
voting interest in STADA Arzneimittel AG, Stadastr. 2-18, 61118 Bad Vilbel,
Germany, and fell below the threshold of 3 % on 24th of August 2012 and
amounts to 0.59 % (349.622 voting rights) on that day.
27.08.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: STADA Arzneimittel AG
StadastraÃe 2-18
61118 Bad Vilbel
Germany
Internet: www.stada.de
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG